We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 501.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMDC
RNS Number : 9607B
Mediclinic International PLC
07 April 2017
Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
7 April 2017
Notification of Major Interest in Mediclinic International plc shares
1. Identity of the issuer or Mediclinic International the underlying issuer plc of existing shares to which voting rights are attached: ----------------------------------------------------------- ----------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------ An acquisition or disposal of voting rights x ------------------------------------------------------------ ---------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------ ---------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------ ---------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------ ---------------------------- Other (please specify): ---------------------------------------------------------- ---------------------------- 3. Full name of person(s) Coronation Asset Management subject to the (Pty) Ltd notification obligation: ----------------------------------------------------------- ----------------------------- 4. Full name of shareholder(s) N/A (if different from 3.): ----------------------------------------------------------- ----------------------------- 5. Date of the transaction 07 April 2017 and date on which the threshold is crossed or reached: ----------------------------------------------------------- ----------------------------- 6. Date on which issuer 07 April 2017 notified: ----------------------------------------------------------- ----------------------------- 7. Threshold(s) that is/are crossed or reached: 5% ----------------------------------------------------------- ----------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ----------------------------------- ------------------------------------------------------------------ Number Number Number Number of % of voting of of of shares voting rights Shares Voting rights Rights ------------- ----------------- ---------------- -------------- ----------------------- ------------------------- Direct Direct Indirect Direct Indirect ------------- ------------- ------------ -------------- --------- ------------ ------------ ----------- 36 084 36 084 36 852 36 852 GB00B8HX8Z88 874 874 189 189 5.00% ----------------- ---------------- -------------- --------- ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument Period may be acquired if the instrument is exercised/ converted. ----------------- --------------- -------------------------------- ------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights instrument period refers to --------------- --------------- -------------- ---------------- ------------------------- ----------------------- Nominal Delta --------------- --------------- -------------- ---------------- ------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ---------------------------------------------------- ---------------------------------------------------------------- 36 852 189 5.00% ---------------------------------------------------- ---------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ------------------------------------------------------------------- Proxy Voting: ------------------------------------------------------------------- 10. Name of the proxy holder: Coronation Asset Management (Pty) Ltd ------------------------------------- ---------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------- ---------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------- ---------------------------- 13. Additional information: ------------------------------------- ---------------------------- 14. Contact name: Jamie Rowland ------------------------------------- ---------------------------- 15. Contact telephone number: +27 21 680 2000 ------------------------------------- ----------------------------
Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South
Africa and on the NSX in Namibia.
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information please contact:
Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUBUURBBASRAR
(END) Dow Jones Newswires
April 07, 2017 09:00 ET (13:00 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions